Published in Trop Anim Health Prod on August 01, 1977
Macrophage activation in murine African trypanosomiasis. Infect Immun (1983) 1.24
Macrophages as primary target cells and mediators of immune dysfunction in African trypanosomiasis. Infect Immun (1981) 1.19
The effect of maternally derived antibodies on the response of calves to vaccination against foot and mouth disease. J Hyg (Lond) (1984) 0.91
Suppression of antibody response to Leptospira biflexa and Brucella abortus and recovery from immunosuppression after Berenil treatment. Infect Immun (1979) 0.89
Hemolytic complement and serum C3 levels in Zebu cattle infected with Trypanosoma congolense and Trypanosoma vivax and the effect of trypanocidal treatment. Infect Immun (1980) 0.79
Effect of chronic Trypanosoma brucei infection on the course of louping ill virus infection in mice. Infect Immun (1979) 0.75
Folate levels and neural tube defects. Implications for prevention. JAMA (1995) 5.42
Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet (1997) 4.11
Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr (1997) 3.75
Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet (1995) 3.70
Translocation as a species conservation tool: status and strategy. Science (1989) 3.31
Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med (1993) 2.69
African bovine trypanosomiasis: the problem of drug resistance. Trends Parasitol (2001) 2.56
Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet (1996) 2.53
Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect (1981) 2.52
Immunological studies on Nippostrongylus brasiliensis infection in the rat: the role of local anaphylaxis. Exp Parasitol (1965) 2.45
Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol (1997) 2.40
Quantitative studies on the kinetics of establishment and expulsion of intestinal nematode populations in susceptible and immune hosts. Nippostrongylus brasiliensis in the rat. Parasitology (1968) 2.25
Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet (2002) 2.25
The nature of immunosuppression in Trypanosoma brucei infections in mice. II. The role of the T and B lymphocytes. Immunology (1974) 2.23
Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet (1997) 2.10
A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM (1995) 2.05
The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet (1999) 1.94
The nature of immunosuppression in Trypanosoma brucei infections in mice. I. The role of the macrophage. Immunology (1974) 1.81
Placental insufficiency and the small-for-dates baby. Am J Obstet Gynecol (1972) 1.72
Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med (1998) 1.72
Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res (1997) 1.71
Status and prospects for success of the endangered species act: a look at recovery plans. Science (1993) 1.68
Vitamin B12 and folate deficiency in later life. Age Ageing (2004) 1.67
Transforming growth factor-beta1 mediates coexpression of the integrin subunit alphaE and the chymase mouse mast cell protease-1 during the early differentiation of bone marrow-derived mucosal mast cell homologues. Clin Exp Allergy (2002) 1.65
An improved serodiagnostic procedure for visceral leishmaniasis. Am J Trop Med Hyg (1990) 1.61
Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol (2001) 1.55
Immunosuppression in Trypanosoma brucei infections in rats and mice. Trans R Soc Trop Med Hyg (1973) 1.53
Subcurative chemotherapy and fatal post-treatment reactive encephalopathies in African trypanosomiasis. Lancet (1992) 1.51
Localisation of the vaso-motor centre. J Physiol (1923) 1.51
Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains. J Hyg (Lond) (1978) 1.47
Mast cells and macromolecular leak in intestinal immunological reactions. The influence of sex of rats infected with Nippostrongylus brasiliensis. Immunology (1971) 1.46
Some aspects of tick-borne diseases of British sheep. Vet Rec (1986) 1.45
The relationship between increased folate catabolism and the increased requirement for folate in pregnancy. BJOG (2000) 1.42
Relapsed parasitaemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes. Contrib Microbiol Immunol (1983) 1.40
Preclinical data supporting first clinical trials of new inactivated vaccines. Lancet (1976) 1.40
Regulation of egg production, worm burden, worm length and worm fecundity by host responses in sheep infected with Ostertagia circumcincta. Parasite Immunol (1995) 1.39
Women and the GMC. Br Med J (Clin Res Ed) (1985) 1.38
Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet (1999) 1.37
The elucidation of the mechanism of folate catabolism in the rat. Biochem Biophys Res Commun (1976) 1.34
The relationship between duration of infection with Trypanosoma brucei in mice and the efficacy of chemotherapy. Parasitology (1977) 1.32
The brain as a source of relapsing Trypanosoma brucei infection in mice after chemotherapy. Int J Parasitol (1979) 1.30
The part played by the ala cinerea in vaso-motor reflexes. J Physiol (1925) 1.25
Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet (1981) 1.25
Immunological clearance of 75Se-labelled Trypanosoma brucei in mice. II. Mechanisms in immune animals. Immunology (1980) 1.24
Nutrition and parasite interaction. Int J Parasitol (1997) 1.21
Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors. Gene Ther (2008) 1.21
A field study of parasitic gastritis in cattle. Vet Rec (1965) 1.21
Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. QJM (1997) 1.21
Use of beta-lactamase to hydrolyse interfering antibiotics in vitamin B12 microbiological assay using Lactobacillus leichmannii. Clin Lab Haematol (1990) 1.18
Identification of a new vitamin B 12 binder (transcobalamin 3) in normal human serum. Br J Haematol (1972) 1.18
Assessment of sensitivity of Trypanosoma congolense to isometamidium chloride: a comparison of tests using cattle and mice. Acta Trop (1988) 1.18
Immunological clearance of 75Se-labelled Trypanosoma brucei in mice. I. Aspects of the radiolabelling technique. Immunology (1979) 1.18
The response of mice infected with T. brucei to the administration of sheep erythrocytes. Trans R Soc Trop Med Hyg (1973) 1.16
Homocysteine and cardiovascular risk. Am J Clin Nutr (2000) 1.13
How hosts control worms. Nature (1997) 1.13
Trouble-free microbiologic serum and red cell folate assays. Am J Med Technol (1974) 1.13
Mechanism of choline O-sulphate utilization in fungi. Biochem J (1968) 1.13
Are common mutations of cystathionine beta-synthase involved in the aetiology of neural tube defects? Clin Genet (1997) 1.13
Immunological unresponsiveness in adult rats to the nematode Nippostrongylus brasiliensis induced by infection in early life. Nature (1966) 1.12
Betaine-homocysteine methyltransferase: organ distribution in man, pig and rat and subcellular distribution in the rat. Clin Sci (Lond) (1991) 1.11
Astrocyte activation correlates with cytokine production in central nervous system of Trypanosoma brucei brucei-infected mice. Lab Invest (1992) 1.11
A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei. Proc Natl Acad Sci U S A (1997) 1.10
Whole-blood folate values in subjects with different methylenetetrahydrofolate reductase genotypes: differences between the radioassay and microbiological assays. Clin Chem (1998) 1.10
The pathology of Trypanosoma brucei infection in the rat. Res Vet Sci (1974) 1.10
Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent. Gene Ther (2008) 1.10
Microbiological assay for vitamin B12 with use of a colistin-sulfate-resistant organism. Clin Chem (1987) 1.10
A comparison of serum folate estimations using two different methods. J Clin Pathol (1973) 1.10
The microbiological uses of 2, 3, 5-triphenyltetrazolium chloride. J Med Lab Technol (1969) 1.09
Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses. J Immunol (1991) 1.09
Immunological unresponsiveness to helminth parasites. I. The pattern of Nippostrongylus brasiliensis infection in young rats. Exp Parasitol (1968) 1.09
Oedema of the umbilical cord and respiratory distress in the newborn. Br J Obstet Gynaecol (1975) 1.08
The use of BHK suspension cells for the commercial production of foot and mouth disease vaccines over a twenty year period. Dev Biol Stand (1985) 1.07
Stability and immunogenicity of empty particles of foot-and-mouth disease virus. Arch Virol (1979) 1.07
Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines. Vaccine (1987) 1.06
Monozygous anencephalic triplets--a case report. J Obstet Gynaecol Br Commonw (1966) 1.04
Loss of ribosomal protein L11 blocks stress activation of the Bacillus subtilis transcription factor sigma(B). J Bacteriol (2001) 1.03
Immunological unresponsiveness to helminth parasites. II. Antibody response and hypersensitivity reaction associated with Nippostrongylus brasiliensis infection in young rats. Exp Parasitol (1969) 1.03
Drug-induced megaloblastic change. Clin Haematol (1980) 1.03
Immunopathology of experimental African sleeping sickness: detection of cytokine mRNA in the brains of Trypanosoma brucei brucei-infected mice. Infect Immun (1991) 1.01
Effect of bile on vitamin B12 absorption. Br Med J (1980) 1.01
The use of the 2 substituted 5-nitroimidazole, Fexinidazole (Hoe 239) in the treatment of chronic T. brucei infections in mice. Z Parasitenkd (1983) 1.01